Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![ReutersLegal Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::334944709.png) Reuters Legal [@ReutersLegal](/creator/twitter/ReutersLegal) on x 100.1K followers
Created: 2025-07-14 13:58:48 UTC

AbbVie's Allergan unit will take rival Revance Therapeutics to trial over allegations that Revance's anti-wrinkle injection Daxxify infringes patents related to Allergan's blockbuster Botox.

Subscribe to The Daily Docket:

![](https://pbs.twimg.com/media/Gv0rhwPacAArsRB.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1944758481577521285/c:line.svg)

[Post Link](https://x.com/ReutersLegal/status/1944758481577521285)

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

ReutersLegal Avatar Reuters Legal @ReutersLegal on x 100.1K followers Created: 2025-07-14 13:58:48 UTC

AbbVie's Allergan unit will take rival Revance Therapeutics to trial over allegations that Revance's anti-wrinkle injection Daxxify infringes patents related to Allergan's blockbuster Botox.

Subscribe to The Daily Docket:

XXX engagements

Engagements Line Chart

Post Link

post/tweet::1944758481577521285
/post/tweet::1944758481577521285